Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $336.39 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $122.09 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $84.72 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $28.45 | 1 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $23.47 | 1 | $0 (2017) |
| ABBVIE INC. | $21.95 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $14.67 | 1 | $0 (2019) |
| Lundbeck LLC | $13.92 | 1 | $0 (2022) |
| PFIZER INC. | $13.92 | 1 | $0 (2024) |
| Allergan Inc. | $13.20 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.87 | 2 | ABBVIE INC. ($21.95) |
| 2022 | $13.92 | 1 | Lundbeck LLC ($13.92) |
| 2020 | $28.45 | 1 | Medtronic Vascular, Inc. ($28.45) |
| 2019 | $99.39 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($84.72) |
| 2018 | $122.09 | 1 | Neurocrine Biosciences, Inc. ($122.09) |
| 2017 | $36.67 | 2 | Valeant Pharmaceuticals North America LLC ($23.47) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/21/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: NEUROLOGY | ||||||
| 01/14/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $84.72 | General |
| 08/01/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: NEUROLOGY | ||||||
| 04/27/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/19/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 548 | 1,172 | $384,022 | $112,839 |
| 2022 | 9 | 494 | 1,071 | $261,039 | $76,234 |
| 2021 | 9 | 479 | 887 | $216,666 | $66,107 |
| 2020 | 10 | 563 | 916 | $240,635 | $75,188 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 217 | 715 | $197,633 | $63,432 | 32.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 107 | $67,196 | $16,943 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 123 | 126 | $65,604 | $16,142 | 24.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 123 | 127 | $35,310 | $10,668 | 30.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 97 | $18,279 | $5,653 | 30.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 157 | 623 | $116,030 | $34,243 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 74 | 163 | $43,446 | $12,727 | 29.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 81 | 83 | $42,482 | $12,556 | 29.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 78 | 82 | $22,314 | $6,608 | 29.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $17,771 | $4,407 | 24.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $6,010 | $1,876 | 31.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 19 | 33 | $5,472 | $1,872 | 34.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 23 | 23 | $5,065 | $1,178 | 23.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $2,449 | $767.42 | 31.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 130 | 369 | $64,846 | $20,370 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 77 | 173 | $44,369 | $14,103 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 71 | 71 | $35,024 | $10,962 | 31.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 38 | 40 | $23,029 | $5,761 | 25.0% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 29 | 91 | $15,834 | $5,028 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 57 | 58 | $14,790 | $4,661 | 31.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 41 | 43 | $9,748 | $2,387 | 24.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 14 | 19 | $4,750 | $1,576 | 33.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 22 | 23 | $4,276 | $1,260 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 111 | 331 | $56,826 | $17,950 | 31.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 103 | 106 | $51,304 | $16,549 | 32.3% |
About Dr. Aneel Kumar, M.D
Dr. Aneel Kumar, M.D is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083814040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aneel Kumar, M.D has received a total of $336.39 in payments from pharmaceutical and medical device companies, with $35.87 received in 2024. These payments were reported across 9 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($336.39).
As a Medicare-enrolled provider, Kumar has provided services to 2,084 Medicare beneficiaries, totaling 4,046 services with total Medicare billing of $330,368. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Hospitalist, Internal Medicine
- Location Memphis, TN
- Active Since 07/18/2007
- Last Updated 02/12/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1083814040
Products in Payments
- INGREZZA (Drug) $122.09
- DALVANCE (Drug) $35.15
- Reveal LINQ (Device) $28.45
- XIFAXAN (Drug) $23.47
- ENTRESTO (Drug) $14.67
- ELIQUIS (Drug) $13.92
- VYEPTI (Biological) $13.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060